Australia-wide dispatch

Quantified
Peptides
Vesugen 20mg — research peptide, lyophilised powder in a glass vial, supplied by Quantified Peptides, Sydney, Australia. For in-vitro research use only.

Peptides

Vesugen

Vesugen (Lys-Glu-Asp) research peptide, a tripeptide from russian peptide bioregulator research. Supplied as a lyophilised powder in 20mg vials.

Supplied as lyophilised powder in a 20mg specification. Storage: -20°C · Keep dry, avoid light. Dispatched from Sydney, Australia-wide.

Product information

About Vesugen

Lys-Glu-Asp (KED)

Research background as published in the scientific literature. Supplied for in-vitro laboratory research only; nothing here is a claim about use in humans or animals.

Vesugen is a synthetic tripeptide with the sequence Lys-Glu-Asp (KED). It is one of the short peptide bioregulators developed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology, and is associated with vascular tissue research.

Vesugen peptide has been studied mainly by that group, in endothelial and neuronal cell cultures and in a small number of animal experiments. The work is preclinical and largely published in Russian journals, and independent replication is limited.

Quantified Peptides supplies Vesugen 20mg as a lyophilised research peptide in a sealed vial, dispatched from Sydney, Australia. It is a reference material for in-vitro research into short regulatory peptides.

Type
Synthetic tripeptide
Sequence
Lys-Glu-Asp
Research Areas
Endothelial cell models, vascular biology, ageing biology
Molecular Formula
C15H26N4O8
Molecular Weight
390.4 g/mol
Research Area
Vascular endothelium
Origin
Russian peptide bioregulator research
Research Models
Endothelial and neuronal cell culture
  1. 01Endothelial Cell ModelsVesugen has been examined in cultures of vascular endothelial cells, where researchers measured markers of proliferation and of endothelial function in the presence of the tripeptide.
  2. 02Gene ExpressionStudies from the Khavinson group report changes in the expression of selected genes and proteins, including proliferation and ageing markers, in cultured cells exposed to the KED peptide.
  3. 03Neuronal ModelsMore recent work has looked at the KED peptide in neuronal cell cultures, examining dendritic spine morphology and gene expression in models relevant to neurodegeneration research.

References

  1. 1Khavinson VKh. Peptides and ageing. Neuro Endocrinol Lett. 2002;23 Suppl 3:11–144.
  2. 2Khavinson VKh, Malinin VV. Gerontological Aspects of Genome Peptide Regulation. Basel: Karger; 2005.
  3. 3PubMed: pubmed.ncbi.nlm.nih.gov/?term=KED+peptide+Khavinson

Also in this range.

Compounds the supplier files alongside this one.

View the range